Today: 10 April 2026
Strategy (MSTR) stock jumps as bitcoin nears $97,000 and a director buys the dip
14 January 2026
2 mins read

Strategy (MSTR) stock jumps as bitcoin nears $97,000 and a director buys the dip

New York, Jan 14, 2026, 10:27 EST

  • Strategy shares jumped roughly 6.5% in early trading, following a bitcoin surge of nearly 5%.
  • A director purchased 5,000 shares through an open-market transaction, as revealed in an SEC filing.
  • Strategy revealed it picked up 13,627 bitcoin last week, financing the purchase by selling shares.

Shares of Strategy Inc rose Wednesday, buoyed by bitcoin’s surge near $97,000 and an unusual insider purchase paired with the company’s fresh crypto buys funded by debt and equity. Formerly MicroStrategy, the stock climbed roughly 6.5% to $184.30 by 10:27 a.m. EST. Bitcoin jumped about 4.9% to $96,858, while Coinbase, a key crypto player, added close to 2%.

This shift counts because Strategy now behaves less like a traditional software company and more like a high-stakes bitcoin play. When bitcoin prices fluctuate, the stock tends to move even more sharply—partly due to the company funding its purchases by issuing more shares.

That dynamic is back in play this week: bitcoin’s rebound has lifted crypto-linked stocks, while traders keep a close eye on Washington. There, a push to overhaul market structure could change how digital assets are regulated and traded across the U.S.

Director Carl Rickertsen picked up 5,000 shares on Jan. 12, paying a weighted average of $155.879 each, per a Form 4 filing. The document noted the shares came through several trades clustered tightly in price. Post-purchase, Rickertsen held 5,000 shares total. SEC

Strategy revealed on Monday it acquired 13,627 bitcoin from Jan. 5 to Jan. 11, spending a total of $1.2471 billion. The average price per coin, fees included, came to $91,519. As of Jan. 11, the company held 687,410 bitcoin, bought for $51.80 billion at an average cost of $75,353 each. The recent purchases were funded by selling common stock and a preferred share class through an at-the-market program, which lets a company sell shares gradually. SEC

This week, U.S. senators rolled out draft legislation to clarify when crypto tokens are securities versus commodities, while boosting the Commodity Futures Trading Commission’s oversight of spot crypto markets. “What is threatening progress is not a lack of policymaker engagement,” said Blockchain Association CEO Summer Mersinger, pointing fingers at pressure from “Big Banks.” Digital Chamber CEO Cody Carbone called the move “encouraging” as the regulatory process advances. Reuters

The rally carries some baggage. Over the past year, Strategy’s stock took a hit as the market premium investors once gave the company as a bitcoin proxy has shrunk considerably. Even after this week’s rebound, shares remain well below last summer’s peaks, Barron’s reported. Barron’s

The setup can reverse quickly. If bitcoin loses its gains, Strategy’s equity could take a sharp hit. The company’s funding relies heavily on ongoing access to capital markets — issuing shares risks diluting current investors, and preferred dividends plus other obligations still demand cash tied to a volatile asset.

Other crypto-linked stocks like Coinbase tend to track each other on days like this. But Strategy is on a different level: it’s basically running a rolling bitcoin-buy program wrapped in a public company, with investors valuing both the coin itself and the firm’s knack for securing funds to keep buying more.

Traders will probably watch bitcoin closely, while also tracking new filings for additional buys, share issuances, or any hints that the market’s appetite for funding the next round is fading.

Stock Market Today

  • West Pharmaceutical Services (WST) Valuation Assessed After Dublin Expansion
    April 10, 2026, 8:48 AM EDT. West Pharmaceutical Services (WST) unveiled a 165,000 sq ft expansion in Damastown, Dublin, boosting capacity for injectable treatments targeting diabetes and obesity. Despite a recent 7.81% share price dip over 90 days, the 1-year return stands at 16.24%, indicating gains for longer-term investors. Trading at $254.80 with an average analyst target of $316.69, WST shows signs of undervaluation according to some estimates projecting a fair value of $338.57 per share. The Dublin expansion underpins expected growth from high-margin drug delivery components and contract manufacturing. However, the price-to-earnings (P/E) ratio at 37.2x surpasses industry averages, highlighting valuation risks if market sentiment worsens. Investors face a crucial test as future earnings and margins will determine if WST can sustain its premium valuation amid softer revenue or tariff pressures.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 8:48 AM EDT West Pharmaceutical Services (WST) Valuation Assessed After Dublin Expansion April 10, 2026, 8:48 AM EDT. West Pharmaceutical Services (WST) unveiled a 165,000 sq ft expansion in Damastown, Dublin, boosting capacity for injectable treatments targeting diabetes and obesity. Despite a recent 7.81% share price dip over 90 days, the 1-year return stands at 16.24%, indicating gains for longer-term investors. Trading at $254.80 with an average analyst target of $316.69, WST shows signs of undervaluation according to some estimates projecting a fair value of $338.57 per share.
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Archer Aviation stock slips despite Needham Buy call as rates stay in focus
Previous Story

Archer Aviation stock slips despite Needham Buy call as rates stay in focus

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away
Next Story

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Go toTop